DDT is classified as a probable human carcinogen by both the U.S. Environmental Protection Agency and the International Agency for Research on Cancer (IARC), which places it in Group 2A. That classification means there is strong evidence DDT causes cancer in animals and limited but real evidence linking it to cancer in humans. The cancers most consistently associated with DDT exposure include liver cancer, breast cancer, testicular cancer, and non-Hodgkin lymphoma.
What the Official Classification Means
IARC uses a tiered system to rank how confident scientists are that a substance causes cancer. Group 1 means “definitely causes cancer in humans.” Group 2A, where DDT sits, means “probably causes cancer in humans.” The distinction isn’t about how dangerous DDT is. It reflects the type of evidence available. Animal studies consistently show DDT causes tumors, particularly in the liver. Human studies show positive associations with several cancer types, but because people are exposed to many chemicals simultaneously, it’s harder to isolate DDT’s role with absolute certainty.
The EPA reached the same conclusion independently, judging DDT to be probably carcinogenic to humans based on animal testing, evidence of genetic damage in living organisms, and the limited human data available.
How DDT Promotes Cancer
DDT doesn’t damage DNA the way radiation or tobacco smoke does. Instead, it works through indirect pathways that push cells toward uncontrolled growth. The most well-established mechanism involves oxidative stress, where DDT triggers the production of reactive molecules that damage DNA over time. In long-term rat studies, markers of this kind of DNA damage increased significantly in animals that developed liver tumors.
DDT also acts as an endocrine disruptor, meaning it mimics estrogen in the body. It activates estrogen receptors and interferes with hormone signaling pathways that control cell growth, survival, and reproduction. This hormonal mimicry is especially relevant for cancers of the breast and reproductive organs. When researchers blocked estrogen receptor activity in lab experiments, DDT’s effects on cell behavior disappeared, confirming that much of its cancer-promoting activity runs through hormone pathways.
A third mechanism involves DDT’s ability to disrupt communication between cells. Healthy cells use gap junctions to exchange signals that regulate growth. DDT inhibits this communication, which can allow precancerous cells to multiply without the normal checks that neighboring cells provide.
Liver Cancer
The liver cancer link has the strongest animal evidence. In a two-year feeding study in rats, the highest dose group developed liver tumors at striking rates: 55% of males developed liver tumors, with 35% of those being malignant carcinomas. Females were also affected but at lower rates, with 40% developing tumors and 5% developing carcinomas. Nearly 100% of high-dose animals of both sexes developed precancerous changes in their liver tissue by the end of the study.
The liver is particularly vulnerable because it’s the organ responsible for processing DDT. As DDT is metabolized, it activates enzymes that generate oxidative stress and promotes cell division in ways that give damaged cells more opportunities to become cancerous.
Breast Cancer and Prenatal Exposure
One of the most striking findings involves breast cancer risk in women who were exposed to DDT before birth. A prospective study that measured DDT levels in pregnant women and then tracked their daughters found that women in the highest exposure group had 3.7 times the risk of developing breast cancer compared to those with the lowest prenatal exposure. This is significant because it suggests a window of vulnerability during fetal development, when the chemical can alter breast tissue in ways that increase cancer risk decades later.
These findings support the idea that DDT’s estrogen-mimicking properties are most dangerous during critical periods of development, when hormones are actively shaping how tissues form and grow. The study’s authors concluded that DDT should be considered both an endocrine disruptor and a predictor of breast cancer risk.
Testicular Cancer
A nested case-control study examined blood samples collected from mothers shortly after delivery and then tracked their sons for testicular cancer over the following 30 to 40 years. What mattered wasn’t just the amount of DDT in the mother’s blood, but the ratio of DDT to its breakdown product DDE. A higher ratio indicates more recent or more active exposure, since the body slowly converts DDT into DDE over time.
Sons of mothers with higher DDT-to-DDE ratios had roughly 3.5 to 5 times the risk of developing testicular cancer, depending on the statistical model used. The association held up after adjusting for the mother’s age, weight, and other factors. Like the breast cancer findings, this points to prenatal exposure as a particularly dangerous window.
Non-Hodgkin Lymphoma
The link between DDT and non-Hodgkin lymphoma is less clear. A pooled analysis of nearly 1,000 cases among U.S. farmers found that those who had used DDT had a modestly elevated risk (about 1.2 times the expected rate). Farmers who used DDT for 15 years or more had a somewhat higher risk of 1.5 times the expected rate. However, when researchers adjusted for exposure to other pesticides, the association largely disappeared. This suggests the initial link may have been driven by other chemicals that DDT users were also handling, rather than DDT itself.
Why DDT Still Matters Decades After the Ban
The United States banned most uses of DDT in 1972, but the chemical persists in the environment and in human bodies for remarkably long periods. When DDT breaks down, its primary metabolite, DDE, lodges in body fat and stays there. DDE has a half-life of 6 to 9 years in the human body, meaning it takes that long for even half of a given amount to be eliminated. Both DDT and DDE have similar cancer-promoting potency based on EPA modeling.
People are still exposed to low levels of DDT and DDE through food, particularly meat, dairy, and fish, where the chemicals accumulate in the fat of animals higher up the food chain. FDA Total Diet Studies from the late 1980s and early 1990s found that infants and toddlers had the highest daily intake relative to their body weight, roughly 0.04 to 0.05 micrograms per kilogram of body weight per day, with adults receiving lower doses. These amounts are far below levels used in animal studies, but the chemical’s persistence means exposure is continuous and cumulative over a lifetime.
DDT is also still used for malaria control in parts of Africa, India, and Southeast Asia under a public health exemption to the Stockholm Convention on Persistent Organic Pollutants. People living in those regions face higher exposures, and the chemical continues to enter the global food chain through environmental cycling.
The Bottom Line on DDT and Cancer Risk
DDT probably causes cancer in humans. The evidence is strongest for liver cancer (based on animal data), breast cancer, and testicular cancer (based on human studies of prenatal exposure). Its role in non-Hodgkin lymphoma is less convincing when other pesticide exposures are accounted for. DDT promotes cancer not by directly mutating DNA but by disrupting hormones, generating oxidative stress, and interfering with the cell communication systems that normally keep growth in check. Because DDT and its breakdown products persist in body fat for years, exposure from decades ago can still be biologically relevant today.